Why You Can't Sleep on Peptides

Your body has one job while you sleep: keep your blood glucose stable enough that your brain and organs can function without triggering an emergency response.

When glucose drops below a certain threshold during the night, your hypothalamus detects the deficit and sends a signal that releases cortisol and epinephrine, which are the hormones your body uses to mobilize stored energy and push blood sugar back up. That cortisol spike is not subtle. It raises your core body temperature, increases heart rate, and pulls you out of the deeper stages of sleep, usually somewhere between two and four in the morning. You wake up feeling wired, anxious, or just inexplicably alert, and most people assume something is wrong with their sleep when the actual problem happened hours earlier.

That is the full chain. Now the question is what peptides have to do with it.

There are two categories of peptides that commonly disrupt nocturnal blood sugar, and they do it through completely different mechanisms.

The first category is incretin-based drugs, things like semaglutide, tirzepatide, and retatrutide. These compounds work by mimicking hormones your gut naturally releases after a meal, which signals your pancreas to release insulin and tells your brain you are full. They work extremely well at suppressing appetite, so well that in the phase 2 retatrutide trial published in the New England Journal of Medicine, participants at the highest dose lost an average of 24.2 percent of their body weight over 48 weeks, which is the kind of number that was essentially unheard of from a single compound before.

That appetite suppression is the mechanism that causes the sleep disruption, but not directly. What happens is that people new to these drugs eat dramatically less than their body is used to, often without realizing how little they are consuming, and they go to bed with genuinely insufficient glycogen stores, which is the form of glucose your liver and muscles hold in reserve to supply the body overnight. When those stores are shallow and there is no ongoing food intake to top them up, blood glucose starts drifting down well before morning and the cortisol alarm goes off.

The second category is GH secretagogues, which are compounds like CJC-1295, ipamorelin, and tesamorelin that work by stimulating your pituitary gland to release pulses of growth hormone. These are usually injected before bed because the body's largest natural GH pulse happens during deep sleep, so stacking an exogenous pulse on top of that is part of the intended protocol.

The problem is that growth hormone is directly anti-insulin, meaning it works against insulin's ability to move glucose into cells, and the mechanism is well established. Growth hormone increases the release of free fatty acids from fat tissue, and those fatty acids compete with glucose for uptake in muscle and liver cells, which raises blood glucose and simultaneously makes insulin less effective at clearing it. A study in Endocrine Reviews described GH as both inhibiting insulin's effects at the liver and reducing peripheral glucose uptake through this fatty acid pathway.

The downstream effect on overnight blood sugar is not theoretical. A study in Diabetologia that looked at the dawn phenomenon, which is the blood sugar rise that naturally happens in the early morning hours, found that nocturnal GH spikes were directly responsible for a roughly 30 percent increase in hepatic glucose production. When researchers suppressed those GH pulses with somatostatin, the dawn phenomenon disappeared. When they artificially restored the GH spikes, it came back. The GH was driving the glucose instability, not something else happening at the same time.

So when someone injects a GH secretagogue before bed and gets a strong pulse during deep sleep, they are recreating that mechanism on purpose for the anabolic benefits, but the metabolic side effect is a blood sugar swing that can drop glucose into a range where the cortisol response kicks in.

If someone is running both an incretin and a GH secretagogue at the same time, both mechanisms are active simultaneously. Chronically suppressed appetite means low glycogen going into the night, and then a GH pulse further disrupts the body's ability to regulate whatever glucose is left. The two effects stack.

The fix follows directly from the mechanism.

If the problem is undereating on an incretin, the solution is making sure total daily calorie intake is genuinely sufficient, not just subjectively comfortable. These drugs make hunger an unreliable signal, which means you have to eat by the clock and by numbers rather than waiting to feel hungry. People who are eating low-carbohydrate or ketogenic diets sometimes ask whether this applies to them, and the honest answer is that it depends on total intake. The liver can maintain blood sugar overnight through a process called gluconeogenesis, which is where it manufactures glucose from amino acids and other non-carbohydrate substrates, and people who are well adapted to low-carb eating often have robust gluconeogenesis. The issue is not the diet type. The issue is when an appetite-suppressing drug reduces intake so severely that even gluconeogenesis cannot keep up.

If the problem is a GH secretagogue causing swings, two adjustments are worth trying. The first is moving the injection a few hours earlier in the evening rather than immediately before bed, which shifts the peak GH pulse slightly and may reduce its overlap with the period of lowest blood sugar. The second is eating a small amount of protein and fat before bed, which gives the liver something to work with and slows the rate at which glucose drifts down overnight. Protein without a significant carbohydrate load keeps insulin from spiking while still providing substrate for gluconeogenesis.

Most people troubleshooting sleep on peptides go straight for sleep supplements or assume they need a different protocol. What they actually need is to understand that their body is doing exactly what it is supposed to do when it senses a metabolic emergency, and the goal is to stop creating the emergency in the first place.

The body does not misfire. It responds to conditions. Change the conditions and the response changes with them.

---

References

1. Perriello G, De Feo P, Torlone E, et al. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 diabetes mellitus by decreasing hepatic and extrahepatic sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990;331:52-59. Finding: Suppressing nocturnal GH spikes with somatostatin abolished the dawn phenomenon; restoring GH spikes reproduced it. Hepatic glucose production increased approximately 30%. Source
2. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009;302:152-177. Finding: GH antagonizes insulin's hepatic and peripheral effects via increased free fatty acid flux and uptake. Source
3. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. New England Journal of Medicine. 2023;3896:514-526. Finding: 24.2% mean weight loss at 12mg dose; significant appetite suppression documented across all dose groups. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness